NCT05422911 · Interventional trial
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Overall registry status Recruiting
Phase 2
Conditions Castrate-sensitive, Castrate-sensitive Prostate Cancer, Metastatic Cancer, Neoplasm, Prostate
Delaware Valley sites
- Corporal Michael J. Crescenz VA Medical Center · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory